Jeil Pharma Holdings (XKRX:002620) Total Liabilities : ₩480,574 Mil (As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Jeil Pharma Holdings Total Liabilities?

Jeil Pharma Holdings's Total Liabilities for the quarter that ended in Mar. 2024 was ₩480,574 Mil.

Jeil Pharma Holdings's quarterly Total Liabilities declined from Sep. 2023 (₩484,508.37 Mil) to Dec. 2023 (₩477,810.92 Mil) but then increased from Dec. 2023 (₩477,810.92 Mil) to Mar. 2024 (₩480,573.64 Mil).

Jeil Pharma Holdings's annual Total Liabilities increased from Dec. 2021 (₩392,107.69 Mil) to Dec. 2022 (₩445,884.55 Mil) and increased from Dec. 2022 (₩445,884.55 Mil) to Dec. 2023 (₩477,810.92 Mil).

Jeil Pharma Holdings Total Liabilities Historical Data

The historical data trend for Jeil Pharma Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharma Holdings Total Liabilities Chart

Jeil Pharma Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

363,437.47

388,110.85

392,107.69

445,884.55

477,810.92

Jeil Pharma Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															454,715.98	465,019.82	484,508.37	477,810.92	480,573.64

Jeil Pharma Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Jeil Pharma Holdings's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	412635.829	+	(11698.042	+	42798.137
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	10678.914)
	=	477,811

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	879996.991	-	402186.068
	=	477,811

Jeil Pharma Holdings's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	415198.2	+	(10919.583	+	42892.302
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	11563.553)
	=	480,574

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	880606.892	-	400033.255
	=	480,574

Jeil Pharma Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of Jeil Pharma Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeil Pharma Holdings (XKRX:002620) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

745-5, Banpo-dong, Seocho-gu, Seoul, KOR, 137-810

Website

https://www.jeilpharm.co.kr

Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Jeil Pharma Holdings (XKRX:002620) Headlines

No Headlines